| http://www.w3.org/ns/prov#value | - When a patient???s non-adherence is with a drug class that has been shown to be as effective in decreasing multiple significant endpoints (mortality and significant morbidities such as heart attacks and strokes), the issue becomes critical to address at every opportunity.
|
